(Q36421046)

14 August 2017

1 reference

title

Management strategies for locally advanced prostate cancer (English)

1 reference

14 August 2017

1 reference

Ashesh B Jani

1

1 reference

14 August 2017

publication date

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

23

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

119-129

1 reference

Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer.

14 August 2017

cites work

1 reference

12 December 2020

A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy

1 reference

12 December 2020

Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer

1 reference

12 December 2020

Analysis of acute toxicity with use of transabdominal ultrasonography for prostate positioning during intensity-modulated radiotherapy

1 reference

12 December 2020

Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999.

1 reference

12 December 2020

The role of high-dose rate brachytherapy in locally advanced prostate cancer

1 reference

12 December 2020

Prostate cancer incidence and mortality rates among white and black men.

1 reference

12 December 2020

The national survey of prostate cancer in the United States by the American College of Surgeons

1 reference

12 December 2020

Prostate brachytherapy: importance of technique

1 reference

12 December 2020

Hormone therapy adjuvant to external beam radiotherapy for locally advanced prostate carcinoma: a complication-adjusted number-needed-to-treat analysis

1 reference

12 December 2020

Intensity-modulated radiation therapy for prostate cancer

1 reference

12 December 2020

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

1 reference

12 December 2020

The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome

1 reference

12 December 2020

Intensity-modulated versus conventional pelvic radiotherapy for prostate cancer: analysis of acute toxicity

1 reference

12 December 2020

Cancer statistics, 2005

1 reference

12 December 2020

Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome

1 reference

12 December 2020

Locally advanced prostate cancer

1 reference

12 December 2020

Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation

1 reference

12 December 2020

Radiation Therapy Oncology Group P-0014: a phase 3 randomized study of patients with high-risk hormone-naive prostate cancer: androgen blockade with 4 cycles of immediate chemotherapy versus androgen blockade with delayed chemotherapy

1 reference

12 December 2020

Management of locally advanced prostate cancer. 1. Staging, natural history, and results of radical surgery

1 reference

12 December 2020

Detection of extracapsular extension of prostate cancer: role of fat suppression endorectal MRI.

1 reference

12 December 2020

Laparoscopic radical prostatectomy

1 reference

12 December 2020

Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer?

1 reference

12 December 2020

Long-term results of a randomized trial for the treatment of Stages B2 and C prostate cancer: radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities.

1 reference

12 December 2020

Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer

1 reference

12 December 2020

PET and prostate cancer

1 reference

12 December 2020

Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report

1 reference

12 December 2020

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.

1 reference

12 December 2020

Fast neutron irradiation for prostate cancer

1 reference

12 December 2020

Re: Neoadjuvant hormonal ablative therapy before radical prostatectomy: a review. Is it indicated?

1 reference

12 December 2020

Prostate cancer. Radiation therapy for localized disease

1 reference

12 December 2020

Prostate cancer epidemiology

1 reference

12 December 2020

Review of current protocols for protontherapy in USA.

1 reference

12 December 2020

Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413

1 reference

12 December 2020

Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate

1 reference

12 December 2020

Early prostate cancer: clinical decision-making

1 reference

12 December 2020

Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report

1 reference

12 December 2020

Endocrine-Induced Regression of Cancers

1 reference

12 December 2020

Noninvasive detection of clinically occult lymph-node metastases in prostate cancer

1 reference

12 December 2020

A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy

1 reference

12 December 2020

Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium

1 reference

12 December 2020

CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity.

1 reference

12 December 2020

Impact on late toxicity of using transabdominal ultrasound for prostate cancer patients treated with intensity modulated radiotherapy

1 reference

12 December 2020

Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancer

1 reference

12 December 2020

Treatment options in hormone-refractory metastatic prostate carcinoma.

1 reference

12 December 2020

Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer

1 reference

12 December 2020

Screening for prostate cancer

1 reference

12 December 2020

Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study

1 reference

12 December 2020

In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.

1 reference

12 December 2020

The effectiveness of combining hormone therapy and radiotherapy in the treatment of prostate cancer

1 reference

12 December 2020

Enhanced therapeutic effect of HSV-tk+GCV gene therapy and ionizing radiation for prostate cancer

1 reference

12 December 2020

Organ motion and IMRT in prostate cancer therapy

1 reference

12 December 2020

Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer

1 reference

12 December 2020

Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locally advanced prostate cancer.

1 reference

12 December 2020

Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate canc

1 reference

12 December 2020

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

1 reference

12 December 2020

Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer

1 reference

12 December 2020

Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Prostate Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Patterns of Care and RTOG studies in prostate cancer: long-term survival, hazard rate observations, and possibilities of cure

1 reference

12 December 2020

Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: feasibility and preliminary results

1 reference

12 December 2020

10.2165/00002512-200623020-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

14 August 2017

1022484748

0 references

1 reference